Laparoscopy to predict the result of primary cytoreductive surgery in advanced ovarian cancer patients (LapOvCa-trial): a multicentre randomized controlled study

The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1471-2407/12/31/prepub ; Background: Standard treatment of advanced ovarian cancer is surgery and chemotherapy. The goal of surgery is to remove all macroscopic tumour, as the amount of residual tumour is the most important prognostic factor for survival. When removal off all tumour is considered not feasible, neoadjuvant chemotherapy (NACT) in combination with interval debulking surgery (IDS) is performed. Current methods of staging are not always accurate in predicting surgical outcome, since approx... Mehr ...

Verfasser: Rutten, M.
Gaarenstroom, K.
Van Gorp, T.
van Meurs, H.
Arts, H.
Bossuyt, P.
Ter Brugge, H.
Hermans, R.
Opmeer, B.
Pijnenborg, J.
Schreuder, H.
Schutter, E.
Spijkerboer, A.
Wensveen, C.
Zusterzeel, P.
Mol, B.
Kenter, G.
Buist, M.
Dokumenttyp: Journal article
Erscheinungsdatum: 2012
Verlag/Hrsg.: BioMed Central
Schlagwörter: Humans / Ovarian Neoplasms / Neoplasm / Residual / Laparoscopy / Survival Analysis / Prospective Studies / Quality of Life / Adult / Aged / 80 and over / Middle Aged / Netherlands / Female / Young Adult
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-29193769
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : http://hdl.handle.net/2440/91560